Malignant pleural mesothelioma masquerading as a chest wall soft tissue tumor
This case report describes a rare instance of biphasic malignant pleural mesothelioma presenting as a localized chest wall mass in a patient without asbestos exposure, emphasizing the critical need for comprehensive immunohistochemical analysis and multidisciplinary evaluation to avoid misdiagnosis and guide appropriate treatment.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer that arises in the lining of the lungs is a rare and aggressive disease. Most often, it spreads out like a thickening sheet along the surface of the lung and the inside of the chest cavity, frequently filling that space with fluid. Doctors usually recognize this pattern quickly because the imaging scans show a widespread problem rather than a single lump. However, in very uncommon situations, this same disease does not spread out. Instead, it grows as a distinct, isolated mass that pushes outward, breaking through the lining and invading the muscles and ribs of the chest wall. When this happens, the tumor looks exactly like a primary growth of the chest wall itself, such as a bone tumor or a soft tissue sarcoma. This visual trickery makes it incredibly difficult for doctors to know what they are fighting before they operate, which can lead to the wrong treatment plan. Understanding how these rare cases hide in plain sight is vital for ensuring patients receive the correct care from the very beginning.
A team of researchers at The Second Xiangya Hospital of Central South University recently documented one of these deceptive cases involving a 67-year-old man. The patient arrived with a noticeable lump on the front right side of his chest and pain that had been building for three months. He had no history of smoking and no confirmed exposure to asbestos, the material most commonly linked to this type of cancer. When doctors scanned his chest, they found a mass measuring 27 mm by 35 mm sitting between his fifth and sixth ribs. A special scan that tracks how much energy cells use showed the lump was extremely active, glowing brightly with a value of 19.1, yet there was no sign that the cancer had spread to lymph nodes or other parts of the body. A needle biopsy, which takes a tiny sample of the tissue, suggested the presence of a poorly differentiated malignant tumor, but it could not definitively say where the cancer came from. The sample showed some markers that pointed toward a lining cell origin, but the evidence was not strong enough to be certain.
Faced with a painful, growing mass that was confirmed to be cancerous, the medical team decided to proceed with surgery to remove it. They performed an extended resection, taking out the tumor along with the adjacent fifth and sixth ribs to ensure clean edges. During the operation, the surgeons also found a tiny, isolated nodule on the inner lining of the chest wall near the fourth rib and removed that as well. The patient recovered quickly and went home four days after the procedure. However, the true nature of the disease only became clear after the removed tissue was studied in detail under a microscope. The final analysis revealed that the tumor was not a primary chest wall cancer, but rather a biphasic malignant pleural mesothelioma. This specific type of cancer contains two different kinds of cells and expressed strong markers for the lining of the lungs, along with a very high rate of cell division. Because the tumor had invaded the chest wall and included the small nodule found during surgery, the cancer was staged as advanced, specifically T4N0M0 stage IIIB.
The story took a difficult turn just two months after the surgery. A follow-up scan showed that new nodules had appeared on the right side of the pleura, indicating the cancer had returned. The medical team discussed the next steps with specialists from different fields and recommended additional treatment to fight the recurrence. The patient declined chemotherapy and chose to return to a local facility for symptom management. By the fourth month after surgery, the recurrent lesions had grown larger, and the patient began to experience shortness of breath. This case highlights a critical challenge in modern medicine: when a tumor presents in an unusual way, a standard needle biopsy might not provide enough information to identify its true origin. The researchers noted that for tumors that look like chest wall masses, doctors need to use a wider range of tests to distinguish between a cancer that started in the chest wall and one that started in the lung lining but moved outward.
The authors of this report emphasize that when a patient presents with a chest wall tumor, it is essential to confirm exactly where the cancer began before deciding on a treatment strategy. In this specific instance, the initial biopsy showed a mix of signals that left the origin unclear, but the patient's severe pain and resistance to further invasive procedures meant the team did not perform a second biopsy or more extensive testing before surgery. While the surgery successfully removed the visible mass, the lack of a definitive preoperative diagnosis meant the full extent of the disease and the most appropriate long-term plan were not established until after the fact. The case serves as a reminder that for atypical tumors, relying on a single test or a standard approach can be risky. To avoid errors in treatment, medical teams should consider using a broader set of markers to trace the tumor's roots and, when necessary, bring together pathologists and surgeons to discuss the best path forward, even if it means repeating a biopsy to get a clearer answer.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.